Aug 30, 2013, 01.58 PM IST The stock movement is on the back of news that its subsidiary Taro Pharmaceutical has entered an exclusive licensing and co-development agreement with Novabiotics for its investigational new drug. ...
23.26 | 0
komentar | Read More